IOVANCE BIOTHERAPEUTICS INC

IOVANASDAQ

🏆 #1452 by market capEarnings Nov 4US Equity

$647.19▲ $28.02 (+4.33%)

Simulated price

1h—

24h▲ 4.3%

7d—

14d—

30d—

1y—

🏦Market Cap

$2.90B

Small Cap

📈Revenue Growth (YoY)

+60.6%

High Growth

📊Gross Margin

116.3%

High

💵FCF Margin

-91.2%

Thin

⚖️P/S Ratio

8.9x

Elevated

Otter Score

60

Fair

Earnings

Q3 · 2026Reported 2026-08-06

Earnings Per Share

Actual

-0.11

Expected

-0.13

beat

+17.60%

YoY +66.70%

Revenue

Actual

$99.31M

Expected

$87.83M

beat

+13.10%

YoY +65.70%

Consensus estimates

Recent quarters

Q3 2026

-0.11

beat

Q2 2026

-0.19

inline

Q1 2026

-0.18

beat

Q4 2025

-0.25

beat